Chipiron

Breast Screening Guideline Debates, Overdiagnosis, and Supplemental MRI Selection

Breast Screening Guideline Debates, Overdiagnosis, and Supplemental MRI Selection

Recent public-facing guidance reinforces annual mammography, MRI for appropriately high-risk women, and prompt diagnostic workup despite recent negative imaging. ASCO guidance supports risk-stratified surveillance and selective MRI, CEM, and ultrasound; density notification has not yet demonstrated improved understanding, equity, or outcomes.

Sources (2)
Updated Oct 4, 2026
Breast Screening Guideline Debates, Overdiagnosis, and Supplemental MRI Selection - Chipiron | NBot | nbot.ai